初次髋膝关节置换术后预防性头孢呋辛与庆大霉素相关急性肾损伤:一项倾向性评分匹配研究
前瞻性队列研究纳入2015年9月1日至2016年11月30日行髋或膝关节置换的2560例患者,比较头孢呋辛单用与联合庆大霉素的急性肾损伤发生率,分别为1.07%与1.36%(P=.524),总体急性肾损伤发生率为1.25%,多因素分析显示静脉使用庆大霉素与急性肾损伤风险增加相关。
要点
- 头孢呋辛单用与联合庆大霉素的急性肾损伤发生率分别为1.07%与1.36%,差异无统计学意义(P=.524)。
- 总体急性肾损伤发生率为1.25%(32/2560),其中31/32例为急性肾损伤网络分期I期。
- 多因素分析显示静脉使用庆大霉素与急性肾损伤风险增加相关。
核心结论
- 头孢呋辛联合或不联合庆大霉素相比高剂量青霉素类方案,感染和急性肾损伤发生率均较低。
- 头孢呋辛联合或不联合庆大霉素是下肢关节置换安全有效的选择。
研究设计与样本
- 前瞻性队列研究,纳入2015年9月1日至2016年11月30日行髋或膝关节置换的患者。
- 预防性静脉抗生素按当地政策给予,急性肾损伤按经验证的急性肾损伤网络标准基于基线血清肌酐变化分级,并进行倾向性评分匹配识别危险因素。
- 共2560例符合纳入标准,女性占多数(1447/2560;56.5%),平均年龄67.5±10.7岁,男性显著更年轻(65.9±10.9 vs 68.7±10.4岁)。
主要发现
- 急性肾损伤发生于32例(1.25%)。
- 头孢呋辛单用与头孢呋辛联合庆大霉素的急性肾损伤发生率分别为1.07%与1.36%,差异无统计学意义(P=.524)。
- 总体31/32例为急性肾损伤网络分期I期。
- 急性肾损伤未影响住院时间。
- 术后感染率为7/2560(0.27%),无艰难梭菌相关性腹泻发生。
临床怎么用
- 作者认为头孢呋辛联合或不联合庆大霉素是下肢关节置换安全有效的选择。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Perioperative acute kidney injury (AKI) can be associated with lower limb arthroplasty and increases morbidity, length of stay, and mortality. AKI is more prevalent in some antibiotic regimes compared with others. The aim of the present study is to assess the impact of cefuroxime (CEF), with or without gentamicin (±G), on AKI rates. METHODS: A prospective cohort study involving patients undergoing hip or knee arthroplasty was performed, between September 1, 2015 and November 30, 2016. Prophylactic intravenous antibiotics were administered according to local policy. AKI was graded according to the validated Acute Kidney Injury Network criteria based on the changes from baseline serum creatinine values. Propensity score matching was performed to identify risk factors. The local audit department approved the study. Appropriate statistical analyses were performed. RESULTS: A total of 2560 met the inclusion criteria, with a female preponderance (1447/2560; 56.5%). The mean age was 67.5 ± 10.7 years, with males being significantly younger (65.9 ± 10.9 vs 68.7 ± 10.4 years). AKI developed in 32 cases (1.25%). There was no difference in AKI rates between CEF alone and CEF in combination with gentamicin (1.07% vs 1.36%; P = .524). Overall 31/32 cases were Acute Kidney Injury Network stage I. AKI did not affect the length of stay. Postoperative infection rate was 7/2560 (0.27%). There were no incidences of Clostridium difficile-associated diarrhea. Multivariate analysis demonstrated an increased AKI risk with the use of intravenous gentamicin. CONCLUSION: C ± G yields low rates of infection and AKI compared with high-dose penicillin-based regimes. It is a safe and effective choice for lower limb arthroplasty.
引用
- Tucker A, Hegarty P, Magill PJ, et al. Acute Kidney Injury After Prophylactic Cefuroxime and Gentamicin in Patients Undergoing Primary Hip and Knee Arthroplasty-A Propensity Score-Matched Study. J Arthroplasty. 2018. PMID: 29807788. doi:10.1016/j.arth.2018.04.044
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。